TP53 and neoplasm: Although YAP1 can facilitate both pro-and anti-tumorigenic activities, it is suggested that LATS kinases are major regulators that maintain wild-type p53 activity and balance the tumor-promoting functions of YAP1 through cooperating with RASSF1A [44,45].